For the quarter ending 2025-09-30, IRWD made $122,060,000 in revenue. $40,080,000 in net income. Net profit margin of 32.84%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Total revenues | 122,060,000 | 85,239,000 | 41,143,000 | 82,711,000 |
| Research and development | 22,468,000 | 23,373,000 | 27,432,000 | 25,603,000 |
| Selling, general and administrative | 21,908,000 | 16,795,000 | 24,260,000 | 35,597,500 |
| Restructuring, net | 2,200,000 | -250,000 | 18,559,000 | 255,000 |
| Total costs and expenses | 46,576,000 | 39,918,000 | 70,251,000 | 61,455,500 |
| Income from operations | 75,484,000 | 45,321,000 | -29,108,000 | 21,255,500 |
| Interest expense and other financing costs | 8,434,000 | 8,356,000 | 8,070,000 | 8,072,500 |
| Interest and investment income | 930,000 | 818,000 | 869,000 | 973,500 |
| Other | 40,000 | 39,000 | 37,000 | 160,000 |
| Other income (expense), net | -7,464,000 | -7,499,000 | -7,164,000 | -6,779,000 |
| Income before income taxes | 68,020,000 | 37,822,000 | -36,272,000 | 14,476,500 |
| Income tax expense | 27,940,000 | 14,223,000 | 1,114,000 | 15,429,500 |
| Net income (loss) | - | - | - | -953,000 |
| Net income (loss) | 40,080,000 | 23,599,000 | -37,386,000 | -953,000 |
| Earnings per share, basic | 0.25 | 0.15 | -0.23 | 0 |
| Earnings per share, diluted | 0.23 | 0.14 | -0.23 | 0 |
| Weighted average number of shares outstanding, basic | 162,215,000 | 161,723,000 | 160,974,000 | -79,818,500 |
| Weighted average number of shares outstanding, diluted | 177,764,000 | 176,837,000 | 160,974,000 | -79,581,000 |
IRONWOOD PHARMACEUTICALS INC (IRWD)
IRONWOOD PHARMACEUTICALS INC (IRWD)